Botanix Revises Securities Purchase Plan Timetable and Sets Approval Date

An announcement from Botanix Pharmaceuticals Limited ( (AU:BOT) ) is now available.

Botanix Pharmaceuticals has updated investors on its proposed issue of securities tied to a securities purchase plan, confirming it has released a prospectus and revised the SPP timetable. The offer under the SPP will now open on 11 March 2026 and close on 13 April 2026, aligning the capital-raising schedule with regulatory and shareholder approval milestones.

A shareholder meeting to approve the issue of securities is set for 1 April 2026, with the company planning to issue the new securities on 20 April 2026, subject to that approval. The revised timetable provides shareholders with clearer visibility on key dates for participation in the SPP and signals continued use of equity markets to support Botanix’s funding needs and strategic initiatives.

The most recent analyst rating on (AU:BOT) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Botanix Pharmaceuticals Limited stock, see the AU:BOT Stock Forecast page.

More about Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Ltd is an Australian-listed pharmaceutical company focused on developing and commercialising dermatology and other therapeutics. The company operates in the life sciences sector, using clinical-stage drug development to address unmet medical needs in its target markets.

Average Trading Volume: 9,220,497

Technical Sentiment Signal: Sell

Current Market Cap: A$119.8M

See more insights into BOT stock on TipRanks’ Stock Analysis page.